Hikma

Jazz, Hikma must face 'reverse payment' claims over narcolepsy drug
Reuters
Tue, 08/27/24 - 10:32 pm
Jazz Pharma
Hikma
Xyrem
reverse payments
legal
Antibiotics specialist Xellia plots 247 layoffs on the heels of Ohio plant sale to Hikma
Fierce Pharma
Tue, 06/25/24 - 09:06 pm
Hikma
Xellia
antibiotics
layoffs
Merck’s Bridion Could Face Generic Pressure from Hikma Ahead of Patent Expiry Date
BioSpace
Tue, 02/27/24 - 10:18 am
Merck
patents
Hikma
Bridion
muscle relaxants
generics
Ad firm Publicis, drugmaker Hikma settle US opioid cases for $500 million
Reuters
Thu, 02/1/24 - 10:58 pm
Publicis
Hikma
opioids
opioid crisis
legal
In antitrust suit, Hikma says Amarin locked up exclusive supply deals to shut out Vascepa generics
Fierce Pharma
Fri, 02/24/23 - 08:55 am
Amarin
Hikma
legal
antitrust
generics
Vascepa
Digital health firm Altibbi raises $44m in round backed by Hikma
Pharmaforum
Mon, 03/28/22 - 07:53 pm
Altibbi
Hikma
digital health
funding
telehealth
ESC: Amarin touts Vascepa's ability to reduce repeat heart problems as it fights generic with 'skinny label' claim
Fierce Pharma
Mon, 08/23/21 - 11:32 pm
Amarin
Vascepa
Hikma
FDA approves the first generic for Amarin's Vascepa — but is a launch imminent?
Endpoints
Fri, 05/22/20 - 11:03 am
FDA
Amarin
Vascepa
Hikma
generics
Chasing Mylan, Hikma tries again with rejected generic Advair in US
Pharmaforum
Wed, 11/27/19 - 10:47 am
Hikma
FDA
generics
GSK
Advair
asthma
COPD
Hikma Pharmaceuticals acquires manufacturing platform, two pipeline products from Insys Therapeutics
Stockmarket Wire
Fri, 08/9/19 - 10:42 am
Hikma
INSYS Therapeutics
M&A
drug manufacturing
GSK wins new reprieve as Hikma's generic Advair delayed again
Yahoo/Reuters
Tue, 03/13/18 - 11:45 am
GSK
Hikma
generics
Advair
Drugmaker Hikma's U.S. unit raises medicine prices: Financial Times
Reuters
Tue, 08/22/17 - 12:07 am
Hikma
drug pricing
West-Ward Pharmaceuticals
Glaxo scores again as FDA strikes down would-be Advair copycats Hikma, Vectura
Fierce Pharma
Thu, 05/11/17 - 11:49 am
GSK
FDA
Advair
Hikma
Vectura
Jazz Pharmaceuticals stock surges 7% on settlement with Hikma over generic drug
Marketwatch
Thu, 04/6/17 - 09:36 am
Jazz Pharmaceuticals
Hikma
generics
Xyrem
narcolepsy
Hikma to buy Boehringer's U.S. generic drug business for $2.65 billion
Yahoo/Reuters
Tue, 07/28/15 - 10:04 am
Hikma
Boehringer Ingelheim
generics
M&A
Boehringer charges ahead with sale of U.S. generics biz with bids from Hikma, Mallinckrodt
Fierce Pharma
Tue, 06/30/15 - 11:14 am
Boehringer Ingelheim
generics
Hikma
Mallinckrodt
Perrigo Company
M&A
Mylan said to be eyeing a $7B-plus bid for rising star Hikma
Fierce Pharma
Wed, 01/28/15 - 01:14 pm
Mylan Labs
M&A
Hikma
Hikma Pharmaceuticals receives warning over Portugal facility
Proactive Investors, UK
Sat, 10/25/14 - 11:01 am
Hikma
Boehringer Ingelheim to sell US injectable generics business to Hikma for up to $300 million
First Word Pharma
Wed, 05/28/14 - 10:07 am
Boehringer Ingelheim
Hikma
injectables
M&A
Hikma Has Up to $600 Million for Acquisitions, Darwazah Says
Bloomberg
Sun, 05/26/13 - 11:19 am
Hikma

Pages